Monocytes of distinct clinical types of leprosy are differentially activated by cross-linking class II HLA molecules to secrete IL-12

Hideki Ohyama, Nahoko Kato, Kazu Takeuchi, Yoshihiko Soga, Yasushi Uemura, Fusanori Nishimura, Sho Matsushita

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Leprosy is characterized by a wide spectrum of clinical features depending on the individual differences in Th1-type immunity. The objective of this study was to evaluate whether monocyte activation by stimulus via class II HLA molecules would be correlated with the differences in cellular immune responses among diverse clinical forms of leprosy. IL-1β and IL-12 productivity in monocyte preparations obtained from PBMCs was estimated in patients with lepromatous- and tuberculoid-type leprosy. We found that monocytes from lepromatous patients produced significantly higher (about 4-fold higher) amounts of IL-12 as compared to in patients with tuberculoid type of leprosy when class II HLA molecules were cross-linked with anti-HLA class II antibodies, whereas almost equal amounts of IL-1β were produced from each monocyte preparation by stimulus via class II HLA molecules regardless of the clinical form of leprosy. These results suggest that monocyte activation differs between lepromatous and tuberculoid patients in terms of IL-12 secretion, which might be related to individual differences in the cellular immune responses according to the clinical type of leprosy.

Original languageEnglish
Pages (from-to)271-274
Number of pages4
JournalAPMIS
Volume112
Issue number4-5
DOIs
Publication statusPublished - Apr 1 2004
Externally publishedYes

Fingerprint

Leprosy
Interleukin-12
Monocytes
Tuberculoid Leprosy
Interleukin-1
Individuality
Cellular Immunity
Lepromatous Leprosy
Immunoglobulin Isotypes
Immunity

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Immunology and Allergy
  • Microbiology (medical)

Cite this

Monocytes of distinct clinical types of leprosy are differentially activated by cross-linking class II HLA molecules to secrete IL-12. / Ohyama, Hideki; Kato, Nahoko; Takeuchi, Kazu; Soga, Yoshihiko; Uemura, Yasushi; Nishimura, Fusanori; Matsushita, Sho.

In: APMIS, Vol. 112, No. 4-5, 01.04.2004, p. 271-274.

Research output: Contribution to journalArticle

Ohyama, Hideki ; Kato, Nahoko ; Takeuchi, Kazu ; Soga, Yoshihiko ; Uemura, Yasushi ; Nishimura, Fusanori ; Matsushita, Sho. / Monocytes of distinct clinical types of leprosy are differentially activated by cross-linking class II HLA molecules to secrete IL-12. In: APMIS. 2004 ; Vol. 112, No. 4-5. pp. 271-274.
@article{ad7cab5703be4bdc84a82e8dc7d2102d,
title = "Monocytes of distinct clinical types of leprosy are differentially activated by cross-linking class II HLA molecules to secrete IL-12",
abstract = "Leprosy is characterized by a wide spectrum of clinical features depending on the individual differences in Th1-type immunity. The objective of this study was to evaluate whether monocyte activation by stimulus via class II HLA molecules would be correlated with the differences in cellular immune responses among diverse clinical forms of leprosy. IL-1β and IL-12 productivity in monocyte preparations obtained from PBMCs was estimated in patients with lepromatous- and tuberculoid-type leprosy. We found that monocytes from lepromatous patients produced significantly higher (about 4-fold higher) amounts of IL-12 as compared to in patients with tuberculoid type of leprosy when class II HLA molecules were cross-linked with anti-HLA class II antibodies, whereas almost equal amounts of IL-1β were produced from each monocyte preparation by stimulus via class II HLA molecules regardless of the clinical form of leprosy. These results suggest that monocyte activation differs between lepromatous and tuberculoid patients in terms of IL-12 secretion, which might be related to individual differences in the cellular immune responses according to the clinical type of leprosy.",
author = "Hideki Ohyama and Nahoko Kato and Kazu Takeuchi and Yoshihiko Soga and Yasushi Uemura and Fusanori Nishimura and Sho Matsushita",
year = "2004",
month = "4",
day = "1",
doi = "10.1111/j.1600-0463.2004.apm11204-0507.x",
language = "English",
volume = "112",
pages = "271--274",
journal = "APMIS : acta pathologica, microbiologica, et immunologica Scandinavica",
issn = "0903-4641",
publisher = "Blackwell Munksgaard",
number = "4-5",

}

TY - JOUR

T1 - Monocytes of distinct clinical types of leprosy are differentially activated by cross-linking class II HLA molecules to secrete IL-12

AU - Ohyama, Hideki

AU - Kato, Nahoko

AU - Takeuchi, Kazu

AU - Soga, Yoshihiko

AU - Uemura, Yasushi

AU - Nishimura, Fusanori

AU - Matsushita, Sho

PY - 2004/4/1

Y1 - 2004/4/1

N2 - Leprosy is characterized by a wide spectrum of clinical features depending on the individual differences in Th1-type immunity. The objective of this study was to evaluate whether monocyte activation by stimulus via class II HLA molecules would be correlated with the differences in cellular immune responses among diverse clinical forms of leprosy. IL-1β and IL-12 productivity in monocyte preparations obtained from PBMCs was estimated in patients with lepromatous- and tuberculoid-type leprosy. We found that monocytes from lepromatous patients produced significantly higher (about 4-fold higher) amounts of IL-12 as compared to in patients with tuberculoid type of leprosy when class II HLA molecules were cross-linked with anti-HLA class II antibodies, whereas almost equal amounts of IL-1β were produced from each monocyte preparation by stimulus via class II HLA molecules regardless of the clinical form of leprosy. These results suggest that monocyte activation differs between lepromatous and tuberculoid patients in terms of IL-12 secretion, which might be related to individual differences in the cellular immune responses according to the clinical type of leprosy.

AB - Leprosy is characterized by a wide spectrum of clinical features depending on the individual differences in Th1-type immunity. The objective of this study was to evaluate whether monocyte activation by stimulus via class II HLA molecules would be correlated with the differences in cellular immune responses among diverse clinical forms of leprosy. IL-1β and IL-12 productivity in monocyte preparations obtained from PBMCs was estimated in patients with lepromatous- and tuberculoid-type leprosy. We found that monocytes from lepromatous patients produced significantly higher (about 4-fold higher) amounts of IL-12 as compared to in patients with tuberculoid type of leprosy when class II HLA molecules were cross-linked with anti-HLA class II antibodies, whereas almost equal amounts of IL-1β were produced from each monocyte preparation by stimulus via class II HLA molecules regardless of the clinical form of leprosy. These results suggest that monocyte activation differs between lepromatous and tuberculoid patients in terms of IL-12 secretion, which might be related to individual differences in the cellular immune responses according to the clinical type of leprosy.

UR - http://www.scopus.com/inward/record.url?scp=3442889451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3442889451&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0463.2004.apm11204-0507.x

DO - 10.1111/j.1600-0463.2004.apm11204-0507.x

M3 - Article

VL - 112

SP - 271

EP - 274

JO - APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

JF - APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

SN - 0903-4641

IS - 4-5

ER -